|
|
 |
|
Viewing report
|
|
|
|
BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis
GlobalData, Sep 2011, Pages: 48
BioMimetic Therapeutics, Inc. (BMTI) - Product Pipeline Analysis
Summary
BioMimetic Therapeutics, Inc. (BioMimetic) is a biotechnology company utilizing purified recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. It is engaged in the development and commercialization of drug-device combination products that enhance the healing of orthopedic, periodontal, craniofacial and sports injuries. Further, the company’s range of products and product candidates combine recombinant protein therapeutics with tissue specific scaffolds that stimulate tissue healing and regeneration. The company has three wholly owned subsidiaries. The company is headquartered in Franklin, US
This report is a source for data, analysis and actionable intelligence on the BioMimetic Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
BioMimetic Therapeutics, Inc. (BMTI) - Financial and Strategic SWOT Analysis Review
Tissue Regeneration Technologies, LLC - Product Pipeline Analysis
Tengion, Inc. (TNGN) - Product Pipeline Analysis
Advanced BioHealing, Inc. - Product Pipeline Analysis
Artimplant AB (ARTI B) - Product Pipeline Analysis
Stratatech Corporation - Product Pipeline Analysis
Nanovis Incorporated - Product Pipeline Analysis
Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis
Small Bone Innovations, Inc. - Product Pipeline Analysis
Medtronic, Inc. (MDT) - Product Pipeline Analysis
|
|
|
|
